Ubs Group Ag Immunity Bio, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,680,582 shares of IBRX stock, worth $3.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,680,582

Previous 1,190,647 41.15%

Holding current value

$3.5 Million

Previous $3.14 Million 31.53%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.24 - $3.01 $1.1 Million - $1.47 Million	489,935 Added 41.15%	1,680,582 $4.13 Million
Q2 2025 Aug 14, 2025	SELL	$1.89 - $3.44 $468,283 - $852,325	-247,769 Reduced 17.23%	1,190,647 $3.14 Million
Q1 2025 May 13, 2025	SELL	$2.32 - $3.9 $346,313 - $582,164	-149,273 Reduced 9.4%	1,438,416 $4.33 Million
Q4 2024 Feb 14, 2025	BUY	$2.56 - $6.17 $3.02 Million - $7.29 Million	1,181,256 Added 290.64%	1,587,689 $4.06 Million
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $172,049 - $347,207	-51,822 Reduced 11.31%	406,433 $1.51 Million

Q2 2024 Aug 13, 2024	SELL	$4.82 - $9.15 $2.25 Million - $4.28 Million	-467,234 Reduced 50.49%	458,255 $2.9 Million
Q1 2024 May 13, 2024	BUY	$3.23 - $6.17 $2.85 Million - $5.45 Million	882,777 Added 2066.81%	925,489 $4.97 Million
Q4 2023 Feb 09, 2024	BUY	$1.25 - $5.21 $3,662 - $15,265	2,930 Added 7.37%	42,712 $214,000
Q3 2023 Nov 09, 2023	BUY	$1.29 - $3.1 $90 - $217	70 Added 0.18%	39,782 $67,000
Q2 2023 Aug 11, 2023	SELL	$1.53 - $6.41 $114,238 - $478,609	-74,666 Reduced 65.28%	39,712 $110,000
Q1 2023 May 12, 2023	SELL	$1.35 - $4.78 $343,203 - $1.22 Million	-254,225 Reduced 68.97%	114,378 $208,000
Q4 2022 Feb 08, 2023	BUY	$4.35 - $6.77 $1.1 Million - $1.71 Million	252,685 Added 217.99%	368,603 $1.87 Million
Q3 2022 Nov 10, 2022	BUY	$3.65 - $6.43 $240,334 - $423,383	65,845 Added 131.5%	115,918 $576,000
Q2 2022 Aug 10, 2022	SELL	$2.68 - $6.14 $329,524 - $754,955	-122,957 Reduced 71.06%	50,073 $186,000
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $918,882 - $1.37 Million	-181,957 Reduced 51.26%	173,030 $971,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $432,552 - $776,611	76,288 Added 27.37%	354,987 $2.16 Million
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $2.31 Million - $3.58 Million	251,520 Added 925.42%	278,699 $2.71 Million
Q2 2021 Aug 13, 2021	SELL	$13.41 - $22.4 $386,677 - $645,904	-28,835 Reduced 51.48%	27,179 $388,000
Q1 2021 May 12, 2021	BUY	$12.83 - $42.25 $718,659 - $2.37 Million	56,014 New	56,014 $1.33 Million

Others Institutions Holding IBRX

# of Institutions

297

Shares Held

137M

Call Options Held

2.59M

Put Options Held

3.35M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $833M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account